NYSE: AEON - AEON Biopharma, Inc.

Yield per half year: -63.18%
Dividend yield: 0.00%
Sector: Healthcare

Share chart AEON Biopharma, Inc.


About AEON Biopharma, Inc.

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins for the treatment of debilitating medical conditions. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Fort Lauderdale, Florida.


IPO date 2021-04-12
ISIN US00791X1000
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.aeonbiopharma.com
Цена ао 0.6999
Change price per day: -1.22% (0.41)
Change price per week: -4.88% (0.4258)
Change price per month: -38.78% (0.6615)
Change price per 3 month: +218.9% (0.127)
Change price per half year: -63.18% (1.1)
Change price per year: -94.3% (7.1)
Change price per 3 year: -95.86% (9.79)
Change price per year to date: -32.43% (0.5994)

Underestimation

Title Value Grade
P/S 0 0
P/BV -1.4 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 1.16

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -26.47 0
Yield Ebitda, % -4.05 0
Yield EPS, % -100.19 0
Total: 0



Head Job title Payment Year of birth
Mr. Marc Forth Principal Financial Officer, President, CEO & Director 1.13M 1971 (54 years)
Dr. Chad K. Oh M.D. Chief Medical Officer 587.4k 1959 (66 years)
Mr. Alex Wilson Executive VP, Chief Legal Officer & Corporate Secretary N/A 1987 (38 years)
Ms. Jennifer Sy Principal Accounting Officer 1985 (40 years)

Address: United States, Irvine. CA, 5 Park Plaza - open in Google maps, open in Yandex maps
Website: https://www.aeonbiopharma.com